Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in REGENERON PHARMACEUTICALS
JACOBS LEVY EQUITY MANAGEMENT, INC holds 214,160 shares of REGN (REGENERON PHARMACEUTICALS), worth $165.5M as of 2026-Q1. The position was decreased (-19.2% shares). REGN represents 0.7% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.
Current Value
$165.5M
Current Shares
214,160
Total Value Change
+$151.4M
Total Shares Change
+200,782
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 214,160 |
-19.2% |
| $165.5M |
| 0.7% |
| $766.66 |
0 |
| 2025-Q4 | Decreased | 264,991 | -8.0% | $204.5M | 0.8% | $773.94 | 0 |
| 2025-Q3 | Increased | 287,881 | +22.9% | $161.9M | 0.6% | $560.05 | 52 |
| 2025-Q2 | Increased | 234,267 | +313x | $123M | 0.5% | $519.56 | 58 |
| 2025-Q1 | Decreased | 747 | -11.8% | $473,770 | 0.0% | $634.66 | 0 |
| 2024-Q4 | Decreased | 847 | -96.4% | $603,344 | 0.0% | $698.71 | 0 |
| 2024-Q3 | Increased | 23,591 | +76.3% | $24.8M | 0.1% | $1,036.94 | 43 |
| 2024-Q2 | Increased | 13,378 | +3595.6% | $14.1M | 0.1% | $1,045.23 | 45 |